Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Symptom network connectivity indices as predictors of relapse in major depressive disorder
Abraham Nunes1, Barbara Pavlova1, John-Jose Nuñez2
1Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada; Mood Disorders Program, Nova Scotia Health Authority, Halifax, NS, Canada.
Abstract:
Major Depressive Disorder (MDD) demonstrates heterogeneous symptom profiles and a high relapse risk. Understanding how symptom interactions relate to relapse in MDD may enhance maintenance strategies. We thus investigated how connectivity in depressive symptom networks relates to relapse in MDD. We analyzed longitudinal data from 87 patients with remitted MDD who were followed for an average of 12 months. Patient-level symptom networks were estimated using multilevel graphical vector autoregression applied to weekly self-ratings of the Quick Inventory of Depressive Symptomatology. We calculated patient-specific network connectivity indices, including symptom network density (SND), vertex cover (VC) size, and minimal dominating set (MDS) size. Cox proportional hazards models assessed associations between these indices and time to relapse, controlling for baseline symptom severity. Higher SND and larger VC size were significantly associated with an increased relapse risk (HR for SND = 2.03, 95 % CI [1.44, 2.87], p < 0.001; HR for VC = 2.77, 95 % CI [1.79, 4.30], p < 0.001). Conversely, a larger MDS size was associated with a lower risk of relapse (HR 0.47, 95 % CI [0.31, 0.70], p < 0.001). Exploratory analyses showed that the strength centrality of sadness, difficulty concentrating, pessimism, suicidality, and low interest portend a higher relapse risk. Hyperconnectivity among depressive symptom networks may indicate vulnerability to relapse in MDD. Our results further support the potential utility of symptom network-based analyses for predicting outcomes in MDD. Future studies should evaluate whether symptom network-based analyses can provide markers for personalized treatment planning.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

